Agnieszka A. Kaczor - Concepedia

Author

Agnieszka A. Kaczor

Also Known As

A. A. Kaczor, A. Kaczor, A.A. Kaczor, Agnieszka A Kaczor, Agnieszka A. Kaczor, Agnieszka Anna Kaczor, Agnieszka KACZOR, Agnieszka Kaczor, Kaczor, A., Kaczor, A.A.

191

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Medical University of Lublin University of Eastern Finland Maria Curie-Skłodowska University Center for Research in Molecular Medicine and Chronic Diseases University of Siedlce

About

Agnieszka A. Kaczor is an author at Medical University of Lublin specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	23	520
2	Biochemistry	12	16	357
3	Engineering	8	8	159
4	Natural Sciences	8	8	217
5	Social Sciences	1	1	38

Agnieszka A. Kaczor

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Chiral 1,3,4-Oxadiazol-2-ones as Highly Selective FAAH Inhibitors Jayendra Z. Patel, Teija Parkkari, Tuomo Laitinen, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryChiral 1,3,4-Oxadiazol-2-onesSeparated EnantiomersPharmaceutical Science	2013	66
Structure‐Based Virtual Screening for Dopamine D<sub>2</sub> Receptor Ligands as Potential Antipsychotics Agnieszka A. Kaczor, Andrea Silva, Peter Kolb, ChemMedChem	2016	57
Thyroid Peroxidase Activity is Inhibited by Phenolic Compounds—Impact of Interaction Ewa Habza-Kowalska, Agnieszka A. Kaczor, Justyna Żuk, Molecules	2019	57
Caspases in Alzheimer’s Disease: Mechanism of Activation, Role, and Potential Treatment Piotr Wójcik, Michał K. Jastrzębski, Agata Zięba, Molecular Neurobiology	2023	43
Interplay between Two Allosteric Sites and Their Influence on Agonist Binding in Human μ Opioid Receptor Damian Bartuzi, Agnieszka A. Kaczor, Dariusz Matosiuk Journal of Chemical Information and Modeling	2016	41
In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic Agnieszka A. Kaczor, Katarzyna M. Targowska‐Duda, Barbara Budzyńska, Neurochemistry International Behavioral StudiesMedicinal ChemistryNeuropsychologyPsychoactive DrugPsychiatry	2016	38
What are the challenges with multi-targeted drug design for complex diseases? Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk, Expert Opinion on Drug Discovery	2022	36
The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics Agnieszka A. Kaczor, Manuela Jörg, Ben Capuano Journal of Molecular Modeling Molecular DockingHomobivalent AntagonistsEngineeringFunctional SelectivityMedicine	2016	35
Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity Maciej Woś, Małgorzata Miazga‐Karska, Agnieszka A. Kaczor, Biomedicine & Pharmacotherapy Medicinal ChemistryAntimicrobial Drug Discoveryα-Glucosidase InhibitorsPharmaceutical ChemistryBiochemistry	2017	35
Modeling Complexes of Transmembrane Proteins: Systematic Analysis of ProteinProtein Docking Tools Agnieszka A. Kaczor, Jana Selent, Ferrán Sanz, Molecular Informatics	2013	34

Page 1